NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Retrospective Data Collection: Post Study Treatment Anticancer Therapy From IMELDA MO22223

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Breast Cancer

Interventions: No Intervention

Countries: Brazil, France, India, Italy, Spain, Turkey (Türkiye)

This study aims to understand better the effective results from the IMELDA MO22223 P-trial (NCT00929240) and see if the anti-cancer therapies given during its follow-up time after study treatments were terminated possibly had an effect on efficacy results.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

Having been randomized in the IMELDA MO22223 P-trial

Exclusion Criteria:

Not having been randomized in the IMELDA MO22223 P-trial

Locations (32)

Fortaleza, Ceará, Brazil
Rio de Janeiro, Rio de Janeiro, Brazil
Ijuí, Rio Grande do Sul, Brazil
Porto Alegre, Rio Grande do Sul, Brazil
Jaú, São Paulo, Brazil
Santo André, São Paulo, Brazil
São Paulo, São Paulo, Brazil
São Paulo, São Paulo, Brazil
Besançon, France
Chartres, France
Hyères, France
Lille, France
Paris, France
Paris, France
Périgueux, France
Strasbourg, France
Mumbai, Maharashtra, India
New Delhi, National Capital Territory of Delhi, India
Brindisi, Apulia, Italy
Naples, Campania, Italy
Genoa, Liguria, Italy
Alcoy, Alicante, Spain
Sabadell, Barcelona, Spain
Alcazar de S. Juan, Ciudad Real, Spain
Barakaldo, Vizcaya, Spain
Jaén, Spain
Málaga, Spain
Toledo, Spain
Valencia, Spain
Ankara, Turkey (Türkiye)
+ 2 more on CT.gov